Page last updated: 2024-10-29

ketoconazole and Xeroderma

ketoconazole has been researched along with Xeroderma in 3 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kamalam, A1
Thambiah, AS1
Hazen, PG2
Walker, AE1
Stewart, JJ1
Carney, JF1
Engstrom, CW1
Turgeon, KL1
Carney, P1
Lynch, WS1

Other Studies

3 other studies available for ketoconazole and Xeroderma

ArticleYear
Ketoconazole in the treatment of combined infection with dermatophytosis and candidosis.
    Mykosen, 1984, Volume: 27, Issue:5

    Topics: Candidiasis, Cutaneous; Candidiasis, Oral; Child, Preschool; Humans; Ichthyosis; Ketoconazole; Male;

1984
Keratitis, ichthyosis, and deafness (KID) syndrome: management with chronic oral ketoconazole therapy.
    International journal of dermatology, 1992, Volume: 31, Issue:1

    Topics: Administration, Oral; Adult; Candidiasis, Cutaneous; Carcinoma, Squamous Cell; Female; Foot Diseases

1992
Keratitis, ichthyosis, and deafness syndrome with development of multiple cutaneous neoplasms.
    International journal of dermatology, 1989, Volume: 28, Issue:3

    Topics: Adult; Carcinoma, Squamous Cell; Deafness; Female; Humans; Ichthyosis; Keratitis; Ketoconazole; Neop

1989